Light is a “promising” tool in the fight against cancer, say researchers in the US.
A study, published in Nature Medicine, showed how a drug could be created which sticks to tumours, but is then only activated when hit by specific waves of light.
It means a treatment can be highly targeted and not damage the surrounding tissue.
A cancer charity said the treatment showed early promise.
Currently, treatments for cancer can be separated into three categories: blasting it with radiation, surgically removing a tumour or using drugs to kill the cancerous cells. All have side effects and scientists are trying to come up with more precise therapies.
In this study, researchers at the National Cancer Institute, Maryland, used an antibody which targets proteins on the surface of cancerous cells.
They then attached a chemical, IR700, to the antibody. IR700 is activated when it is hit by near infrared light. This wavelength of light can penetrate several centimetres into the skin.
To test the antibody-chemical combination, researchers implanted tumours, squamous cell carcinoma, into the backs of mice. They were given the drug and exposed to near infrared light.
The study said: “Tumour volume was significantly reduced… compared to untreated control mice and survival was significantly prolonged.
“This selective killing minimises damage to normal cells.”
The authors said the combination was “a promising therapeutic and diagnostic agent for the treatment of cancer”.
Bookmark this page for “near infrared light” and check back regularly as these articles update on a very frequent basis. The view is set to “news”. Try clicking on “video” and “2” for more articles.